ResMed
726 hedge funds and large institutions have $20.8B invested in ResMed in 2023 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 254 increasing their positions, 251 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
726
Holders Change
+55
Holders Change %
+8.2%
% of All Funds
11.45%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.14%
New
95
Increased
254
Reduced
251
Closed
37
Calls
$189M
Puts
$24.9M
Net Calls
+$164M
Net Calls Change
+$145M
Top Buyers
| 1 |
Millennium Management
New York
|
+$138M |
| 2 |
Man Group
London,
United Kingdom
|
+$104M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$89.8M |
| 4 |
Jane Street
New York
|
+$67.6M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$63M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$413M |
| 2 |
BlackRock
New York
|
-$197M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$88.4M |
| 4 |
Amundi
Paris,
France
|
-$69.1M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$56.3M |
